University of California San Francisco

Jennifer C. Price, MD

Jennifer Price - 144
Jennifer
Price
MD

Associate Clinical Professor of Medicine

Hepatology and Liver Transplantation

Department of Medicine

Address

513 Parnassus Avenue MSB, #357M
San Francisco, CA 94143
United States

    Biography

    Dr. Jennifer Cohen Price is an Assistant Clinical Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include liver disease in HIV infection, the natural history and treatment of viral hepatitis, and nonalcoholic fatty liver disease. 

    Dr. Price received her medical degree at Johns Hopkins University School of Medicine in 2004. She continued her medical training at Johns Hopkins, where she completed her residency, gastroenterology and hepatology fellowship, and transplant hepatology fellowship.  She is a fellow of the American College of Physicians, and a member of the American College of Gastroenterology, American Gastroenterological Association, and American Association for the Study of Liver Diseases.  Dr. Price is certified by the American Board of Internal Medicine in internal medicine and gastroenterology. 

    Education

    Institution Degree Dept or School End Date
    Johns Hopkins Hospital Fellowship in Gastroenterology Department of Medicine
    Johns Hopkins Hospital Fellowship in Transplant Hepatology Department of Medicine
    Johns Hopkins Hospital Internship and Residency Department of Medicine
    Johns Hopkins University Ph.D. Bloomberg School of Public Health
    Johns Hopkins University M.D. School of Medicine
    Stanford University B.A.

    Board Certifications

    American Board of Internal Medicine
    American Board of Internal Medicine - Gastroenterology

    Awards & Honors

    Award Conferred By Date
    Delta Omega Public Health Honor Society Johns Hopkins Bloomberg School of Public Health 2016
    ACG Junior Faculty Development Award American College of Gastroenterology 2015
    Gilead Research Scholars Program in HIV Gilead Sciences 2015
    UCSF Hellman Fellows Award Hellman Fellows Fund 2015
    Pilot Award Program in HIV/AIDS UCSF Resource Allocation Program 2014
    ACG Clinical Research Pilot Award American College of Gastroenterology 2012
    Clinical Research Scholars KL2 Award Johns Hopkins University School of Medicine 2009
    Johns Hopkins Department of Medicine Award for Outstanding Teaching by a Fellow Johns Hopkins Hospital 2008
    Alpha Omega Alpha Johns Hopkins University School of Medicine 2004
    W. Bradford Patterson Fellowship Dana-Farber Cancer Institute 1999
    Phi Beta Kappa Stanford University 1999

    Clinical Expertise

    Alcoholic Liver Disease

    Autoimmune Hepatitis

    Cirrhosis

    Drug-Induced Hepatitis

    Fulminant Hepatic Failure

    Hemochromatosis

    Hepatitis B

    Hepatitis C

    Hepatocellular Carcinoma (Liver Cancer)

    Liver Transplantation

    Living Donor Liver Transplantation

    Nonalcoholic Fatty Liver Disease

    Polycystic Liver Disease

    Primary Biliary Cirrhosis

    Primary Sclerosing Cholangitis

    Program Affiliations

    UCSF Liver Center

    Grants and Funding

    • San Francisco Bay Clinical Trials Unit (CTU) | NIH | 2007-03-02 - 2027-11-30 | Role: Co-Investigator
    • Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults | NIH | 2023-09-15 - 2026-07-31 | Role: Co-Principal Investigator
    • SF Bay Area MACS/WIHS Combined Cohort Study | NIH | 2019-04-01 - 2026-03-31 | Role: Co-Principal Investigator
    • Ancillary Studies of NAFLD and NASH in HIV infected Adults | NIH | 2020-03-21 - 2025-01-31 | Role: Co-Investigator

    Research Interests

    Hepatocellular carcinoma (HCC)

    Liver injury and repair (Liver transplantation)

    Liver disease and HIV

    Nonalcoholic fatty liver disease

    Viral hepatitis 

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
    1. Non-Hispanic Black Persons With HIV Have a Lower Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease and Clinically Significant Fibrosis Compared to Non-Hispanic White and Hispanic Individuals.
      Woreta TA, Gawrieh S, Wilson LA, Xin Y, Vilar-Gomez E, Corey KE, Sterling RK, Lake JE, Naggie S, Heath S, Crandall H, Price JC, Loomba R, Chalasani N, Sulkowski MS| | PubMed
    2. Social needs screening in hepatology clinic: a qualitative study of patient experience.
      Kim RG, Ballantyne A, Lancaster E, Galyean P, Sharareh N, Wallace A, Inadomi JM, Zickmund S, Conroy MB, Price JC| | PubMed
    3. Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trial.
      Falade-Nwulia O, Price JC, Feld JJ, Eaton E, Franco RA, Barnaba B, Brown D, Hussain S, Verinumbe T, Wren C, Karimi-Sari H, Hirose K, Cavacuiti C, O'rear ST, Capraru C, Tobin K, Vaidya D, Schwartz S, Sulkowski M| | PubMed
    4. Performance Evaluation of the Xpert® HCV test on Fingerstick Blood in a Prospective Observational Clinical Study at CLIA-Waived Sites in the United States.
      Havens JR, Fluker SA, Schimmel J, McCrary LM, Miller LS, Udo T, Manabe YC, Luetkemeyer A, Burkholder G, Moon AM, Chastain CA, Price JC, Cafardi J, Gallegos-Orozco JF, Young BA, Young J, Aparicio C, Song Y, Lai E, Louw GE| | PubMed
    5. Immune profiling links autoimmune hepatitis to human herpesvirus 6 and relaxin receptor antigens.
      Klepper A, Asaki J, Caspar CM, Kung AF, Vazquez SE, Bodansky A, Mitchell A, Mann SA, Zorn K, Avila-Vargas I, Kari S, Tekeste M, Castro J, Lee B, Duarte M, Khalili M, Yang M, Wolters P, Price J, Perito E, Feng S, Maher JJ, Wilson MR, Lai JC, Weiler-Normann C, Lohse AW, DeRisi J, Tana MM| | PubMed
    6. The Obstacle is the Way: Finding a Path to Hepatitis C Elimination.
      Lo Re V, Price JC, Schmitt S, Terrault N, Bhattacharya D, Arohnson A| | PubMed
    7. Assessment of RNA at SVR4 and Treatment Completion as Alternative Measures of Hepatitis C Cure for People Who Inject Drugs.
      McDonell C, Assaf R, McKinney J, Glidden D, Luetkemeyer A, Ayala B, Chan J, Price JC, Morris MD| | PubMed
    8. Erratum: Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV.
      Duarte MJ, Tien PC, Kardashian A, Ma Y, Hunt P, Kuniholm MH, Floris-Moore M, Fischl MA, French AL, Topper E, Konkle-Parker D, Minkoff H, Ofotokun I, Plankey M, Sharma A, Price JC| | PubMed
    9. The association of steatotic liver disease with cardiometabolic criteria and cardiovascular disease risk in a large cohort of people living with human immunodeficiency virus.
      Richard K. Sterling, Alice L. Sternberg, Jordan E. Lake, Susanna Naggie, Sonya Heath, Jennifer C. Price, Laura Wilson, Holly Crandall, Samer Gawrieh, Naga Chalasani, Rohit Loomba, Mark Sulkowski, HIV NASH Clinical Research Network| | UCSF Research Profile
    10. The association of steatotic liver disease with cardiometabolic criteria and cardiovascular disease risk in a large cohort of people living with human immunodeficiency virus.
      Sterling RK, Sternberg AL, Lake JE, Naggie S, Heath S, Price JC, Wilson L, Crandall H, Gawrieh S, Chalasani N, Loomba R, Sulkowski M| | PubMed